Member Info for hahahehehoho

I have no idea about takeovers, so can anyone help me with this following question: if a bidding company didn't have sufficient cash and bid £130m for a company with reserves cash of £130m and was successfully accepted . .... what would happen next ? Aside from a share offer for their own shares , theoretically, the bidding company wouldn't have to pay right? Lol

Cash and assets wise, year end this is worth £4. Cash is at £102m + bank interest +£20-25m net profit to year end. Assets wise is worth £90m. Even after these facts , Ncyt will prob churn out £20m a year net with most sales being towards December .

So probably realistically £5-6 takeover on the cheap

Biosynex might as well bid £130m because that's how much cash Ncyt will have at end of year plus bank interest . Easy win for biosynex to buy a £130m company which has £130m in the bank. Plus they get an extra £100m in additional assets, possible £40m from UK government and £10-20m per annum net profit revenue streams every year

So novacyt had £102 m cash and £100m in assets last report. The cash reserve may only rise to £120-130 m by year end with possible £40m back from the government (50-50). Looks like a bargain takeover coming.

What are the sales on this since covid started ? Any ideas when next placing is?

Yup Hong Kong going into melt down

Nah Ncyt is basically at cash value. Including the asset value we should be at double . Other countries are surging in COVID rates. No brainer

Obviously £100m in cash and $140m in assets means this worth double.

Shorting this is easy money unfortunately

Lol and useless GDR who will never sell a test is worth £50m. Absolute madness

Jazzy, ppl don't like what you say.............because it is true

Another CE submission another period of zero sales. Then eventually another placing. Rinse and repeat. Groundhog Day.

Hang on, doesn't gdr have distribution in South Africa? What's the problem with sales there after 2years? Very strange

Better buy ncyt then .

Should close down again today or for end of week. Ncyt becoming a predictable short.

Problem with novacyt is that the share price is valued to what is going on in the UK rather than the whole entire world of 7 billion ppl

Expected tank here as expected . Too predictable.

I think ppl are just expecting this to be shorted and go down again lol I hope not as ncyt will get $35-45m net profit a year still without the dhsc

Maybe because those two actually make a lot of money from COVID tests and sell globally ?

Maybe because those two actually make a lot of money from COVID tests and sell globally ?